Trials / Completed
CompletedNCT03903861
Galactose Mediated Glycogen Resynthesis
Galactose Mediated Glycogen Resynthesis and the Effects on Metabolism During Subsequent Exercise
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- University of Birmingham · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This study will compare short-term post-exercise muscle glycogen synthesis following combined galactose-glucose, glucose alone or galactose alone ingestion.
Detailed description
Lactose, the sugar contained within milk, consists of glucose and galactose. Post-exercise consumption of a carbohydrate mixture containing glucose with galactose has been shown to accelerate liver glycogen repletion as compared to glucose-only provision. However, the extent to which galactose-glucose combinations influence post-exercise muscle glycogen storage has yet to be determined. Therefore, this study will investigate whether short-term muscle glycogen storage after strenuous endurance exercise is enhanced by combined galactose-glucose or glucose only ingestion as compared to the ingestion of galactose alone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Glucose alone | Young men or women will complete a glycogen depleting bout of exercise followed by the provision of glucose-alone over 4 hours of recovery before a subsequent bout of exercise. |
| OTHER | Galactose alone | Young men or women will complete a glycogen depleting bout of exercise followed by the provision of galactose-alone over 4 hours of recovery before a subsequent bout of exercise. |
| OTHER | Glucose and galactose | Young men or women will complete a glycogen depleting bout of exercise followed by the provision of glucose and galactose over 4 hours of recovery before a subsequent bout of exercise. |
Timeline
- Start date
- 2019-07-01
- Primary completion
- 2020-05-01
- Completion
- 2020-05-01
- First posted
- 2019-04-04
- Last updated
- 2023-01-04
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03903861. Inclusion in this directory is not an endorsement.